Transplantation proceedings最新文献

{"title":"Outcomes and Indications of Early vs Late Allograft Nephrectomy: A Retrospective Analysis From a Tertiary Center","authors":"Ricardo Mendonça Rodrigues ,&nbsp;Lucas Villard ,&nbsp;Alberto Costa Silva ,&nbsp;Teresa Pina Vaz ,&nbsp;João Oliveira ,&nbsp;Tiago Antunes-Lopes ,&nbsp;Carlos Silva ,&nbsp;João Silva","doi":"10.1016/j.transproceed.2025.10.005","DOIUrl":"10.1016/j.transproceed.2025.10.005","url":null,"abstract":"<div><h3>Background</h3><div>Renal allograft nephrectomy remains a complex and high-risk procedure, often performed following graft failure. While its indications and outcomes vary, the optimal timing for nephrectomy remains controversial.</div></div><div><h3>Objective</h3><div>To compare early (≤60 days post-transplant) vs late (&gt;60 days) allograft nephrectomies in terms of clinical indications, surgical outcomes, complications, and mortality in a tertiary care center.</div></div><div><h3>Methods</h3><div>We conducted a retrospective observational study including all patients undergoing renal allograft nephrectomy between January 2010 and July 2024. Patients were stratified into early and late nephrectomy groups. Data were analyzed regarding demographic characteristics, indications, urgency, surgical technique, complications (Clavien-Dindo classification), transfusion requirements, length of stay, and follow-up outcomes.</div></div><div><h3>Results</h3><div>Among 109 nephrectomies (11.0% of 985 transplants), 55 were early and 54 were late. Early nephrectomies were more frequently urgent (87.3% vs 29.6%, <em>P</em> &lt; .001) and associated with higher transfusion rates, longer hospitalization (median 16 vs 10 days, <em>P</em> = .011), and more complications (22.8% vs 12.7%, <em>P</em> = .164). Major indications differed: vascular thrombosis and hemorrhagic shock were predominant in early nephrectomies, while chronic rejection and infection prevailed in late cases. Urgent nephrectomies, irrespective of timing, were linked to significantly higher complication rates (<em>P</em> &lt; .001). No intraoperative deaths occurred, but all 3 postoperative deaths were in the early group.</div></div><div><h3>Conclusions</h3><div>Early allograft nephrectomies, typically performed for urgent complications, are associated with increased morbidity, transfusion needs, and hospital stay. Late nephrectomies, often elective, have been associated with better postoperative outcomes. These findings underscore the need for standardized guidelines and prospective studies to optimize the management of failed renal grafts.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 10","pages":"Pages 1886-1892"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145461035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The 15th Turkish Transplantation Centers Coordination Association (TTCCA) MeetingGaziantep, TurkeyOctober 17-20, 2024Guest Editor: Sukru EmreCo-Guest Editor: Kamil Yalcin Polat","authors":"","doi":"10.1016/S0041-1345(25)00496-8","DOIUrl":"10.1016/S0041-1345(25)00496-8","url":null,"abstract":"","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 9","pages":"Page 1689"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145398356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effectiveness of Variceal Band Application in Preventing Bile Leakage Associated With Trans-Cystic Feeding Catheter in Living-Donor Liver Transplantation","authors":"Adem Tuncer ,&nbsp;Canan Dilay Dirican ,&nbsp;Emrah Sahin ,&nbsp;Veysel Ersan ,&nbsp;Feyza Sönmez Topcu ,&nbsp;Hasret Ayyıldız Civan ,&nbsp;Bülent Unal ,&nbsp;Abuzer Dirican","doi":"10.1016/j.transproceed.2025.06.014","DOIUrl":"10.1016/j.transproceed.2025.06.014","url":null,"abstract":"<div><h3>Objective</h3><div>Despite advancements in surgical techniques, biliary complications remain a significant concern in liver transplantation. This study evaluated the effectiveness of applying a variceal band to the cystic duct stump in preventing bile leakage in patients with a trans-cystic feeding catheter.</div></div><div><h3>Methods</h3><div>The medical records of 328 liver transplant recipients between April 2022 and June 2024 were retrospectively reviewed. A total of 170 patients with trans-cystic external catheters were included in the study. Of these, 116 patients underwent variceal band application to the cystic duct stump, while 54 did not. The 2 groups were compared regarding demographic characteristics, graft weight, number of bile ducts, presence of bile leakage, and MELD scores.</div></div><div><h3>Results</h3><div>Among the 170 patients who underwent living-donor liver transplantation (LDLT), 58.8% were male, and 41.2% were female. Graft weight was significantly higher in the group with the variceal band application (<em>p</em> &lt; .05). Bile leakage from the cystic duct stump occurred in 2 patients in the group without variceal banding, whereas no bile leakage was observed in the variceal band group. These 2 cases were successfully treated with percutaneous catheter placement under radiologic guidance.</div></div><div><h3>Conclusion</h3><div>The variceal band application is an effective and promising method for reducing bile leakage in LDLT patients utilizing a trans-cystic feeding catheter. However, multicenter studies with larger patient cohorts are necessary to more definitively assess the safety and efficacy of this technique.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 9","pages":"Pages 1777-1780"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Monitoring CD3(+) T Cells in Kidney Transplantation and Immunosuppression Adequacy","authors":"Kemal Eyvaz MD, FEBS, FACS,&nbsp;Arif Aslaner MD, FACS,&nbsp;Arif Ata Kiravkazli MD","doi":"10.1016/j.transproceed.2025.06.016","DOIUrl":"10.1016/j.transproceed.2025.06.016","url":null,"abstract":"<div><h3>Background</h3><div>Monitoring CD3(+) T-cell counts in kidney transplant recipients can provide valuable insights into immunosuppressive therapy effectiveness. This study aimed to evaluate the use of CD3(+) T-cell levels as biomarkers for immunosuppression adequacy and to assess their predictive value for acute rejection post-transplantation.</div></div><div><h3>Methods</h3><div>A retrospective review was conducted involving 130 kidney transplant recipients who received induction therapy with antithymocyte globulin (ATG). CD3(+) T-cell percentages and absolute counts were measured using flow cytometry on postoperative day 5. Immunosuppression was maintained with tacrolimus, initiated upon clinical indicators of graft function recovery.</div></div><div><h3>Results</h3><div>Among monitored patients, the median CD3(+) T-cell percentage was 48%, and median absolute count was 0.14 × 10⁹/L. Acute rejection occurred in 9.9% of recipients. Higher CD3(+) T-cell values significantly correlated with acute rejection (64.0% vs 47.5%, <em>p</em> = .011; absolute count 0.28 vs 0.13 × 10⁹/L, <em>p</em> = .032). ROC analysis identified optimal predictive thresholds: 54% for CD3(+) percentage (sensitivity 85.7%, specificity 73.4%) and 0.21 × 10⁹/L for absolute count (sensitivity 85.7%, specificity 75.0%).</div></div><div><h3>Conclusions</h3><div>CD3(+) T-cell monitoring effectively guides individualized immunosuppressive strategies, significantly predicting acute rejection risks and optimizing graft outcomes.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 9","pages":"Pages 1715-1720"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144669246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effect of Portal Vein Variants on the Margin of Error in Graft Volume Calculation in Living Donor Right Lobe Liver Transplantation","authors":"Feyza Sönmez Topcu ,&nbsp;Veysel Ersan ,&nbsp;Emrah Şahin ,&nbsp;Adem Tunçer ,&nbsp;Hasret Ayyıldız Civan ,&nbsp;Abuzer Dirican ,&nbsp;Bülent Ünal","doi":"10.1016/j.transproceed.2025.06.017","DOIUrl":"10.1016/j.transproceed.2025.06.017","url":null,"abstract":"<div><h3>Background</h3><div>Selecting the appropriate graft for living donor liver transplantation requires accurate calculation of estimated graft volume.</div></div><div><h3>Purpose</h3><div>To investigate the error rate in graft volume calculation in the preoperative evaluation of donor liver and the contribution of donor portal vein type to the error margin.</div></div><div><h3>Material and Methods</h3><div>The study included 197 right lobe liver donors. Estimated graft volume calculations based on preoperative radiological images of donors were retrospectively reviewed. Demographic data of the donors and liver portal vein type were recorded. The proportional differences between the weight of the right lobe graft removed during transplantation and the estimated volume were calculated separately according to the portal vein groups. The margin of error in the estimated graft volume measurement and the effect of portal vein type were statistically evaluated.</div></div><div><h3>Results</h3><div>Considering all donors, estimated preoperative volume was calculated to be 6.877% higher than actual graft weight on average. Preoperative estimated graft volume was on average 5.746% higher for Type 1, 8.311% higher for Type 2, and finally 17.883% higher for Type 3 portal vein variant. It was shown that, as the portal vein anatomy in the donor becomes more complex, the negatively proportional difference in preoperative volume estimation increases.</div></div><div><h3>Conclusion</h3><div>Volume estimation showed a negative proportional difference for all three variants of the portal vein. Especially, the presence of a Type 3 portal vein in the liver graft may cause more errors in preoperative graft volume calculation.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 9","pages":"Pages 1773-1776"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Experiences of Potential Living Donors Who Withdrew From Liver Donor Evaluation: A Qualitative Study","authors":"Tugba Nur Oden ,&nbsp;Tufan Gumus ,&nbsp;Sirin Vatansever Durmus ,&nbsp;Alper Uguz","doi":"10.1016/j.transproceed.2025.08.006","DOIUrl":"10.1016/j.transproceed.2025.08.006","url":null,"abstract":"<div><h3>Background</h3><div>Understanding the psychological, emotional, and managerial challenges faced by potential donors is essential for the proper management of the living donor evaluation process, and appropriate solutions need to be developed for these challenges. This study aimed to explore the experiences of potential liver donors who voluntarily withdrew from the living donor evaluation process.</div></div><div><h3>Methods</h3><div>A phenomenological qualitative design was employed. Ten participants who had voluntarily withdrawn from the living donor evaluation process were interviewed. Three main themes were identified: (1) Experiences Related to the Evaluation Process, (2) Reasons for the Withdrawal Decision, and (3) Recommendations regarding the potential donor evaluation process.</div></div><div><h3>Results</h3><div>Positive experiences included adequate information sharing, emotional support, psychiatric consultations, and support from hospital staff. Negative experiences focused on prolonged waiting times, psychological and emotional barriers, systemic and organizational issues. Key reasons for withdrawal included concerns about health and surgical risks, family responsibilities, psychological unpreparedness, and organizational difficulties experienced throughout the evaluation process. Participants suggested accelerating hospital procedures, improving communication with specialists, offering accommodation during the evaluation process, and increasing public awareness about organ donation.</div></div><div><h3>Conclusions</h3><div>The findings emphasize the need to improve the living donor evaluation process. Prioritizing donor candidates, expediting procedures, and developing donor support programs that address physical, emotional, financial, and systemic needs may enhance the effectiveness of living donor transplantation.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 9","pages":"Pages 1691-1696"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"TTCCA 2024 Meeting Preface","authors":"","doi":"10.1016/j.transproceed.2025.10.002","DOIUrl":"10.1016/j.transproceed.2025.10.002","url":null,"abstract":"","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 9","pages":"Page 1690"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145398357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"HALP Score Predicts Early Post-Transplant Outcomes: A 25-Year Retrospective Study on Hepatocellular Carcinoma and Liver Transplantation Outcomes","authors":"Cihan Agalar ,&nbsp;Tufan Egeli ,&nbsp;Anil Aysal ,&nbsp;Mucahit Ozbilgin ,&nbsp;Berkay Sakaoglu ,&nbsp;Nilay Danis ,&nbsp;Emre Karadeniz ,&nbsp;Erhan Tükel ,&nbsp;Ibrahim Astarcioglu ,&nbsp;Ozgul Sagol ,&nbsp;Tarkan Unek","doi":"10.1016/j.transproceed.2025.08.001","DOIUrl":"10.1016/j.transproceed.2025.08.001","url":null,"abstract":"<div><h3>Aim</h3><div>The Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score is an immune nutritional marker associated with prognosis in various malignancies. However, its prognostic significance in liver transplantation (LT) for hepatocellular carcinoma (HCC) remains unexplored. This study investigates the prognostic impact of the HALP score on post-transplant survival and recurrence in HCC patients.</div></div><div><h3>Patients and Methods</h3><div>A retrospective cohort study included 131 patients who underwent Liver Transplantation for HCC between 1998 and 2023. Patients were stratified into high and low HALP groups based on a threshold value of 55.689 determined via receiver operating characteristic (ROC) analysis. Overall survival (OS), disease-free survival (DFS), and perioperative mortality were analyzed using Kaplan-Meier and Cox regression models.</div></div><div><h3>Results</h3><div>The low HALP group exhibited significantly higher perioperative mortality (18.3% vs. 5.6%, <em>P = .</em>003), first-year mortality (30.0% vs. 9.9%, <em>P = .</em>001), and three-year mortality (48.3% vs. 22.5%, <em>P = .</em>001). Overall survival was significantly shorter in the low HALP group (<em>P = .</em>003).</div><div>Multivariate analysis identified low HALP as an independent risk factor for perioperative (OR: 12.76, <em>P = .</em>019; HR: 11.68, <em>P = .</em>021), first-year (OR: 5.19, <em>P = .</em>005; HR: 4.22, <em>P = .</em>007) and third-year mortality (OR: 3.67, <em>P = .</em>01; HR: 2.88, <em>P = .</em>012).</div></div><div><h3>Conclusion</h3><div>The HALP score is a promising prognostic biomarker for predicting early risk in LT candidates with HCC. Integrating HALP into pre-transplant assessment may optimize patient selection and perioperative management, improving post-transplant outcomes.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 9","pages":"Pages 1793-1798"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Living Donor Liver Transplantation in Patients With Portal Vein Thrombosis: A Single-Center Experience","authors":"Emrah Sahin ,&nbsp;Adem Tuncer ,&nbsp;Feyza Sönmez Topcu ,&nbsp;Veysel Ersan ,&nbsp;Hasret Ayyıldız Civan ,&nbsp;Abuzer Dirican ,&nbsp;Bülent Ünal","doi":"10.1016/j.transproceed.2025.08.011","DOIUrl":"10.1016/j.transproceed.2025.08.011","url":null,"abstract":"<div><h3>Background</h3><div>Portal vein thrombosis (PVT) is a significant vascular complication in liver transplant candidates, necessitating modifications in surgical techniques and increasing the risk of postoperative complications. This study aimed to evaluate postoperative thrombotic complications, the need for reoperation, survival, and mortality rates after living donor liver transplantation (LDLT) in patients with preoperative PVT.</div></div><div><h3>Methods</h3><div>Forty-nine patients diagnosed with preoperative PVT undergoing LDLT between July 2021 and August 2024 at our center were retrospectively reviewed. Patients were classified according to the Yerdel classification. Surgical techniques, portal vein reconstruction, associated diseases, MELD/PELD scores, postoperative PVT occurrence, the need for reoperation, and survival data were analyzed.</div></div><div><h3>Results</h3><div>Postoperative PVT developed in 6 patients (12.2%); 3 of these patients (6.1%) required reoperation. Overall, mortality occurred in 13 patients (26.5%); 3 cases were due to non-PVT-related reasons (sepsis following ERCP/PTC or sudden cardiac arrest). The PVT-related mortality rate was 20.4% (10 patients). Mortality was observed in 4 (66.7%) patients with postoperative PVT. Among 8 patients with Yerdel Grade 3-4 PVT, postoperative PVT occurred in 2 patients (25%). Thrombosis occurred in 2 of 6 patients (33.3%) who underwent graft reconstruction; 1 required reoperation. Portal flow was successfully restored in 83.3% of reconstructed cases. Patients developing postoperative PVT had a higher mean MELD/PELD score (22.5 vs. 19.2), an average age of 48.8 years, and equal gender distribution. The mean follow-up period was 14.2 months overall and 7.7 months in patients with postoperative PVT. Comorbidities (diabetes, hypertension, cardiac, or pulmonary pathology) were present in approximately 50% of patients with postoperative PVT and 62% of those who died. The most common preoperative diagnoses were cryptogenic cirrhosis (22.4%), NASH (18.3%), and HBV infection (16.3%).</div></div><div><h3>Conclusion</h3><div>Preoperative PVT significantly correlates with postoperative PVT development and mortality following LDLT. Advanced Yerdel stages, high MELD/PELD scores, and the necessity for portal vein reconstruction increase this risk. Early diagnosis, close imaging follow-up, and proper anticoagulation management postoperatively are crucial. Our findings highlight the importance of a multidisciplinary approach in surgical planning and lay the groundwork for prospective, multi-center studies.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 9","pages":"Pages 1808-1811"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145067111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of Non-neoplastic Portal Vein Thrombosis in Adult Living Donor Liver Transplantation","authors":"Kamil Yalçın Polat ,&nbsp;Şerafettin Yazar ,&nbsp;Ahmet Kargı ,&nbsp;Serdar Aslan ,&nbsp;Bünyamin Gürbulak ,&nbsp;Vusal Abdurrahmanov ,&nbsp;İbrahim Astarcıoğlu","doi":"10.1016/j.transproceed.2025.09.001","DOIUrl":"10.1016/j.transproceed.2025.09.001","url":null,"abstract":"<div><h3>Background</h3><div>Nontumoral portal vein thrombosis (PVT) refers to thrombotic occlusion of the PV, affecting both superior mesenteric vein (SMV) and splenic vein owing to portal hypertension in cirrhotic patients. Nontumoral PVT is more frequent in cirrhotic patients with a prevalence ranging from 10-14% to 25%.</div></div><div><h3>Method</h3><div>We evaluated the prevalence, morbidity (rethrombosis, ascites), mortality survival rates and contributing factors in patients with PVT (preoperative/perioperative) who underwent PV thromboendovenectomy.</div></div><div><h3>Results</h3><div>We performed 522 living donor liver transplantations between November 2021 and 2024; 82 patients (46 male/36 female) had non-neoplastic chronic cruoric PVT. The prevalence of PVT is 15.7%. Forty-four patients were classified as Yerdel I, 19 as Yerdel II, and 19 as Yerdel III; 53 patients (65%) had a Model for End-Stage Liver Disease (MELD) score of &lt;15. Rethrombosis was seen in 4 cases (4.87%) and 2 patients died. Twelve mortalities were seen (14.63 %). Two of the 12 deaths were related to rethrombosis.</div></div><div><h3>Conclusion</h3><div>Our mortality rates were similar in patients with and without PVT, and PVT had no impact on mortality. When chronic PVT is detected, transplantation should not be delayed, even if the MELD score is low, because PVT can progress faster than MELD, ultimately increasing mortality.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 9","pages":"Pages 1804-1807"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145180034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}